Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

darmerica, llc - atipamezole hydrochloride (unii: 2w4279571x) (atipamezole hydrochloride - unii:2w4279571x) -

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

ax pharmaceutical corp - atipamezole hydrochloride (unii: 2w4279571x) (atipamezole hydrochloride - unii:2w4279571x) -

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

grindeks joint stock company - atipamezole hydrochloride (unii: 2w4279571x) (atipamezole - unii:03n9u5jaf6) -

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

darmerica, llc - atipamezole (unii: 03n9u5jaf6) (atipamezole - unii:03n9u5jaf6) -

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - atipamezole hydrochloride - unknown - atipamezole hydrochloride ungrouped active 0.0 - active constituent

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

headway investments pty ltd - atipamezole hydrochloride - unknown - atipamezole hydrochloride ungrouped active 0.0 - active constituent

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - atipamezole hydrochloride - unknown - atipamezole hydrochloride ungrouped active 0.0 - active constituent

Australija - engleski - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - atipamezole hydrochloride - unknown - atipamezole hydrochloride ungrouped active 0.0 - active constituent

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

stat rx usa llc - imipramine pamoate (unii: mc34p30298) (imipramine - unii:ogg85sx4e4) - imipramine hydrochloride 75 mg - for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than other depressive states. one to three weeks of treatment may be needed before optimal therapeutic effects are evident. the concomitant use of monoamine oxidase inhibiting compounds is contraindicated. hyperpyretic crises or severe convulsive seizures may occur in patients receiving such combinations. the potentiation of adverse effects can be serious, or even fatal. when it is desired to substitute imipramine pamoate capsules in patients receiving a monoamine oxidase inhibitor, as long an interval should elapse as the clinical situation will allow, with a minimum of 14 days. initial dosage should be low and increases should be gradual and cautiously prescribed. the drug is contraindicated during the acute recovery period after a myocardial infarction. patients with a known hypersensitivity to this compound should not be given the drug. the possibility of cross-sensitivity to other dibenzazepine compounds shoul

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

darmerica, llc - atipamezole hydrochloride (unii: 2w4279571x) (atipamezole - unii:03n9u5jaf6) -